Trial Search Results

SZMN Blocks for Pain Control in Pediatric Patients Undergoing T&A

The suprazygomatic maxillary nerve (SZaMN) block is a well-established, safe and effective regional technique for pain management following cleft palate procedures, however, have not been studied for patients undergoing tonsillectomy and adenoidectomy (T&A) procedures. The goals of this study are to determine if SZaMN block can be utilized for pain control and decrease morbidity in pediatric patients undergoing T&A.

Stanford is currently accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):

Intervention(s):

  • Procedure: SZaMN Block

Phase:

N/A

Eligibility


Inclusion Criteria:

   - Ages 0-18

   - Give consent/parental consent to participate in study

   - Patients undergoing tonsillectomy and adenoidectomy

Exclusion Criteria:

   - Participants who do not consent or have parental consent

   - Patients who are clinically unstable or require urgent/emergent intervention

   - Patients under age 6 months

Ages Eligible for Study

6 Months - 18 Years

Genders Eligible for Study

All

Now accepting new patients

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Audrey S Horn, BS
5034078994
Not Recruiting